Published in Dig Dis Sci on April 01, 2000
Crystal structure of oxidized flavodoxin, an essential protein in Helicobacter pylori. Protein Sci (2002) 0.98
cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi'an area. World J Gastroenterol (2003) 0.92
A study of recombinant protective H.pylori antigens. World J Gastroenterol (2002) 0.84
Research progress on Helicobacter pylori outer membrane protein. World J Gastroenterol (2005) 0.83
Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori. World J Gastroenterol (2003) 0.81
Helicobacter pylori-specific immune responses of children: implications for future vaccination strategy. Clin Diagn Lab Immunol (2002) 0.76
Cloning and sequence analysis of gene oipA encoding an outer membrane protein of human Helicobacter pylori. World J Gastroenterol (2004) 0.75
Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay. World J Gastroenterol (2006) 0.75
Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins. World J Gastroenterol (2004) 0.75
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Campylobacter pylori and peptic ulcer disease. Gastroenterology (1989) 7.42
Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun (1990) 5.85
Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73
Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet (1992) 4.54
A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc (1996) 2.22
Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med (1996) 1.96
The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA (1995) 1.94
Helicobacter pylori factors associated with disease development. Gastroenterology (1997) 1.77
Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol (1996) 1.62
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci (1997) 1.34
Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol (1996) 1.34
Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig Dis Sci (1998) 1.27
Possible role of Helicobacter pylori serology in reducing endoscopy workload. Postgrad Med J (1994) 1.21
Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol (1998) 1.15
Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol (1994) 1.14
Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia. Br J Cancer (1998) 1.08
Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol (1997) 1.07
CagA and the outcome of Helicobacter pylori infection. Am J Clin Pathol (1996) 1.05
The influence of size or number of biopsies on rapid urease test results: a prospective evaluation. Gastrointest Endosc (1996) 0.99
What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology (1997) 0.96
Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci (1997) 0.93
Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of association with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol Med Microbiol (1994) 0.91
Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group. Gut (1998) 0.90
Antibody to a Helicobacter pylori species specific antigen in patients with adenocarcinoma of the stomach. Biochem Biophys Res Commun (1998) 0.86
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. J Formos Med Assoc (1998) 0.79
Uptake on Helicobacter pylori research. Pathogenesis and host response. Eur J Gastroenterol Hepatol (1997) 0.75
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc (1996) 2.22
An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol (2000) 2.14
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest (2001) 1.85
Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol (1993) 1.84
Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol (1996) 1.71
Gas in hepatic veins: a rare and critical presentation of emphysematous pyelonephritis. J Urol (1994) 1.60
The normal adult human liver biopsy: a quantitative reference standard. Hepatology (1998) 1.60
Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology (2000) 1.58
Spontaneous rupture of hepatocellular carcinoma. A review of 141 Taiwanese cases and comparison with nonrupture cases. J Clin Gastroenterol (1995) 1.55
Easier hepatic resections with a straight needle. Am J Surg (2001) 1.52
Coherent quasiparticle weight and its connection to high-T(c) superconductivity from angle-resolved photoemission. Phys Rev Lett (2001) 1.45
Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. J Med Virol (1992) 1.28
A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy (2002) 1.27
Clinical analysis of choledochoduodenal fistula with cholelithiasis in Taiwan: assessment by endoscopic retrograde cholangiopancreatography. Am J Gastroenterol (1996) 1.12
Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. Hum Pathol (1997) 1.11
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J Formos Med Assoc (2000) 1.07
A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology (2007) 1.05
Central nervous system candidiasis in very low-birth-weight premature neonates and infants: US characteristics and histopathologic and MR imaging correlates in five patients. Radiology (1998) 1.03
Splenic infarction after histoacryl injection for bleeding gastric varices. Gastrointest Endosc (1998) 1.02
Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders. Dig Dis Sci (2001) 0.99
Bleeding peptic ulcer--risk factors for rebleeding and sequential changes in endoscopic findings. Gut (1994) 0.97
The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas. Radiol Med (2009) 0.95
K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res (1997) 0.95
Liver volume in patients with or without chronic liver diseases. Hepatogastroenterology (1998) 0.95
Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci (1995) 0.94
Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients. Am J Kidney Dis (2001) 0.94
Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci (1997) 0.93
Fatal coxsackievirus B infection in early infancy characterized by fulminant hepatitis. J Infect (1998) 0.92
Implications of Helicobacter pylori serological titer for the histological severity of antral gastritis. Endoscopy (1997) 0.91
Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Arch (1997) 0.90
Quantitative result of 13C urea breath test at 15 minutes may correlate with the bacterial density of H. pylori in the stomach. Hepatogastroenterology (1999) 0.89
C-reactive protein for the evaluation of acute abdominal pain. Am J Emerg Med (1996) 0.88
Diffusion tensor imaging of normal-appearing white matter in neuromyelitis optica. J Neuroradiol (2011) 0.88
When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding. Gastrointest Endosc (1996) 0.87
Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication. Aliment Pharmacol Ther (2007) 0.86
Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing. Liver (1996) 0.86
Clinical significance of ultrasonography, computed tomography, and biochemical tests in the rapid diagnosis of gallstone-related pancreatitis: a prospective study. Pancreas (1988) 0.85
Lower-dose (13)C-urea breath test to detect Helicobacter pylori infection-comparison between infrared spectrometer and mass spectrometry analysis. Aliment Pharmacol Ther (2000) 0.85
Diagnostic efficacy of (13)C-urea breath test for Helicobacter pylori infection in hemodialysis patients. Am J Kidney Dis (2000) 0.85
[Study on effect of emodin on the isolated intestinal smooth muscle of guinea-pigs]. Zhongguo Zhong Xi Yi Jie He Za Zhi (1994) 0.84
Diffuse intramural duodenal hematoma complicated by lethal necrotizing pancreatitis after endoscopic duodenal biopsy. Endoscopy (2008) 0.84
Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma. Anticancer Res (1997) 0.84
Development of Helicobacter pylori infection model in BALB/c mice with domestic cagA-positive and -negative strains in Taiwan. Dig Dis Sci (1999) 0.84
A clinical study of 130 patients with biliary tract cancers and periampullary tumors. Oncology (1997) 0.83
Influence of paraesophageal venous collaterals on efficacy of endoscopic sclerotherapy for esophageal varices. Hepatology (1994) 0.83
Selection of lower cutoff point of [13C]urea breath test is helpful to monitor H. pylori eradication after proton pump inhibitor-based triple therapy. Dig Dis Sci (2000) 0.82
Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol (1994) 0.82
Active, bleeding marginal ulcer of Billroth II gastric resection: a clinical experience of 18 patients. Am J Gastroenterol (1994) 0.82
Carbon urea breath test is not as accurate as endoscopy to detect Helicobacter pylori after gastrectomy. Gastrointest Endosc (2000) 0.81
Characterization of a proximal element in the rat preadipocyte factor-1 (Pref-1) gene promoter. Eur J Biochem (2001) 0.81
Indicators of liver excretory function in patients undergoing biliary decompression for obstructive jaundice. Hepatogastroenterology (1998) 0.81
Toxic effects of cholelitholytic solvents on gallbladder and liver. A piglet model study. Dig Dis Sci (1995) 0.81
Expression of basic fibroblast growth factor, nerve growth factor, platelet-derived growth factor and transforming growth factor-beta in human brain abscess. Acta Neuropathol (1994) 0.80
In vitro and in vivo studies for modified ethyl cyanoacrylate regimens for sclerotherapy. J Biomed Mater Res (2000) 0.80
Pulmonary cavernous hemangiomatosis treated with interferon alfa-2a. Pediatr Cardiol (1996) 0.80
Chronic calcifying pancreatitis in Taiwan: a multicentric study and comparison with western countries. Hepatogastroenterology (1997) 0.79
Hepatic adenoma: an observation from asymptomatic stage to rupture. Hepatogastroenterology (1996) 0.79
Prenatal diagnosis of otocephaly using two-dimensional and three-dimensional ultrasonography. Ultrasound Obstet Gynecol (1998) 0.79
Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma. Dig Dis Sci (1998) 0.79
The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc (1995) 0.79
Endoscopic removal of a large intragastric foreign body with an overtube: a case report. Zhonghua Yi Xue Za Zhi (Taipei) (1994) 0.79
The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence. Anticancer Res (1999) 0.79
One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. J Formos Med Assoc (1998) 0.79
Basic fibroblast growth factor in experimental and clinical bacterial meningitis. Pediatr Res (1999) 0.78
Interactive 3-D virtual colonoscopy system. IEEE Trans Inf Technol Biomed (1999) 0.78
Sequential endoscopic findings in spontaneous intramural hematoma of the esophagus. Endoscopy (1996) 0.78
Vibrio vulnificus infection complicated by acute respiratory distress syndrome in a child with nephrotic syndrome. Pediatr Pulmonol (2000) 0.78
Caroli's disease and congenital hepatic fibrosis associated with polycystic kidney disease. A case presenting with acute focal bacterial nephritis. Clin Nephrol (1992) 0.77
Percutaneous and endoscopic management of bile leak following endoscopic stone retrieval--a case report. Hepatogastroenterology (1999) 0.77
Erythrocyte Lewis antigen phenotypes of dyspeptic patients in Taiwan--correlattion of host factor with Helicobacter pylori infection. J Formos Med Assoc (2001) 0.77
Biliary sludge and pigment stone formation in bile duct-ligated guinea pigs. Dig Dis Sci (1999) 0.77
Hepatofugal flow on computed tomography of arterial portography: its correlation with esophageal varices bleeding. Hepatogastroenterology (2001) 0.77
Bacteremia in acute pancreatitis of different etiologies. J Formos Med Assoc (1995) 0.77
Human biliary beta-glucuronidase activity before and after relief of bile duct obstruction: is it the major role in the formation of pigment gallstones? J Gastroenterol Hepatol (2000) 0.77
Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections. J Formos Med Assoc (1995) 0.77
Clinical assessment of the bacterial load of Helicobacter pylori on gastric mucosa by a new multi-scaled rapid urease test. J Gastroenterol Hepatol (1997) 0.76
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia. Dig Liver Dis (2001) 0.76
Prospective study comparing two iodine concentrations for multidetector computed tomography of the pancreas. Radiol Med (2010) 0.76
Ni-Ti memory alloy clamp plate for fracture of short tubular bone. Chin Med J (Engl) (1992) 0.76